← Leaderboards
Stephanie Subasic Markovina
University Of Wisconsin-Madison
$3,179,459
Attributed
$4,147,041
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,147,041 · 5
By mechanism
R01$1,663,113 · 2
R37$1,270,410 · 1
K08$1,132,466 · 1
F30$81,052 · 1
Top collaborators
- Jessika Contreras2 shared
- Surbhi Grover1 shared
- Ann Klopp1 shared
Most similar at University Of Wisconsin-Madison
Same institution · by research overlap
- Barbara King$1,310,723
- Linsey M Steege$2,325,698
- David J. Gladstone$1,625,428
- Brian William Pogue$26,364,458
- David Gregor Scott Barnett$90,664
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseCellsTumorResistanceNeoplastic CellRecurrencePathway InteractionsMalignant Neoplasm Of Cervix UteriMediatingMolecularBiochemicalCell LineChemoradiationIn VivoIn VitroRadiation ResistanceCervix NeoplasmsCessation Of LifeMalignant NeoplasmsRadiation ResponseRadiation TherapyRegulationBiologyMutant
Grant awards (13)
Accelerated Brachytherapy Forward Chemoradiation Therapy (ABC-RT) for Cervical Cancer$635,516
R37 · FY2025 · CA · contact PI
The role of SERPINB3 in cervical cancer therapeutic resistance$559,091
R01 · FY2025 · CA · contact PI
Defining a globally accessible and pragmatic predictive signature (GAPPS) for locally advanced cervical cancer$498,565
R01 · FY2025 · CA
Accelerated Brachytherapy Forward Chemoradiation Therapy (ABC-RT) for Cervical Cancer$634,894
R37 · FY2024 · CA · contact PI
The role of SERPINB3 in cervical cancer therapeutic resistance$605,457
R01 · FY2024 · CA · contact PI
Mechanisms of radiation-induced tumor cell death and survival in cervical cancer$223,704
K08 · FY2023 · CA · contact PI
Mechanisms of radiation-induced tumor cell death and survival in cervical cancer$225,436
K08 · FY2022 · CA · contact PI
Mechanisms of radiation-induced tumor cell death and survival in cervical cancer$228,234
K08 · FY2021 · CA · contact PI
Mechanisms of radiation-induced tumor cell death and survival in cervical cancer$226,318
K08 · FY2020 · CA · contact PI
Mechanisms of radiation-induced tumor cell death and survival in cervical cancer$228,774
K08 · FY2019 · CA · contact PI
Role of NF-kB Activity in Muyltiple Myeloma$24,628
F30 · FY2009 · AG · contact PI
Role of NF-kB Activity in Muyltiple Myeloma$28,392
F30 · FY2008 · AG · contact PI
Role of NF-kB Activity in Muyltiple Myeloma$28,032
F30 · FY2007 · AG · contact PI